Germany · Delayed Price · Currency is EUR Clearbridge Health Statistics
Total Valuation
FRA:5C6 has a market cap or net worth of EUR 2.85 million. The enterprise value is 4.10 million.
| Market Cap | 2.85M |
| Enterprise Value | 4.10M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 4.30B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +93.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.86% |
| Owned by Institutions (%) | 2.07% |
| Float | 2.82B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.42 |
| PB Ratio | 0.31 |
| P/TBV Ratio | 3.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.33 |
| EV / Sales | 0.60 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.13 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.73 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.22 |
| Interest Coverage | -7.66 |
Financial Efficiency
Return on equity (ROE) is -25.58% and return on invested capital (ROIC) is -12.86%.
| Return on Equity (ROE) | -25.58% |
| Return on Assets (ROA) | -11.01% |
| Return on Invested Capital (ROIC) | -12.86% |
| Return on Capital Employed (ROCE) | -21.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 128 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 22.55 |
Taxes
| Income Tax | -12,037 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 47.18 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:5C6 had revenue of EUR 6.87 million and -1.76 million in losses. Loss per share was -0.00.
| Revenue | 6.87M |
| Gross Profit | 3.41M |
| Operating Income | -2.22M |
| Pretax Income | -2.07M |
| Net Income | -1.76M |
| EBITDA | -2.07M |
| EBIT | -2.22M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 859,290 in cash and 971,633 in debt, giving a net cash position of -112,343.
| Cash & Cash Equivalents | 859,290 |
| Total Debt | 971,633 |
| Net Cash | -112,343 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 9.31M |
| Book Value Per Share | 0.00 |
| Working Capital | 1.45M |
Cash Flow
In the last 12 months, operating cash flow was -733,573 and capital expenditures -65,533, giving a free cash flow of -799,106.
| Operating Cash Flow | -733,573 |
| Capital Expenditures | -65,533 |
| Free Cash Flow | -799,106 |
| FCF Per Share | n/a |
Margins
Gross margin is 49.71%, with operating and profit margins of -32.29% and -25.65%.
| Gross Margin | 49.71% |
| Operating Margin | -32.29% |
| Pretax Margin | -30.11% |
| Profit Margin | -25.65% |
| EBITDA Margin | -30.20% |
| EBIT Margin | -32.29% |
| FCF Margin | n/a |
Dividends & Yields
FRA:5C6 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -93.03% |
| Shareholder Yield | -93.03% |
| Earnings Yield | -61.77% |
| FCF Yield | -28.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:5C6 has an Altman Z-Score of -5.99 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.99 |
| Piotroski F-Score | 4 |